0
Skip to Content
Biologic Eye Drops
Home
FAQ
FAQ
Report problems to the FDA
Report deceptive advertising
Watch & Learn
Browse All
A Patient's Story
DrB's Educational Presentations
Non-Preserved Eye Drop Safety
Regener-Eyes
StimulEyes
Sludge ™
The Placebo Effect
FDA Compliance
On Label, Off Label or No Label?
Placentas from Strangers
History
DEF Open Letter to Key Opinion Leaders (Nov 7, 2024)
FDA Warning Letter to Regenerative Processing Plant (Aug 16, 2024)
FDA Warning Letter to Neobiosis (June 5, 2024)
FDA Inspection Form 483 - RPP Tampa (June 23, 2023)
FDA Inspection Form 483 - RPP Palm Harbor (June 30, 2023)
DEF Open Letter to the FDA (May 12, 2023)
DEF Open Letter to the Eye Care Press (May 5, 2023)
DEF Open Letter to ABB Optical and Dry Eye Rescue (May 1, 2023)
FDA Public Safety Notification on Amniotic Fluid Eyedrops (Apr 10, 2023)
DEF Open Letter re StimulEyes (Mar 9, 2023)
DEF Open Letter to Regener-Eyes (Mar 5, 2023)
FDA Untitled Letter re StimulEyes (Nov 17, 2022)
FDA Untitled Letter to Regener-Eyes (Oct 5, 2022)
DEF Open Letter to Regener-Eyes (Sep 29, 2022)
DEF Regulatory Compliance Summary Information (June 8, 2022)
DEF Open letter for Eye Care Professionals (May 16, 2022)
Biologic Eye Drops
Home
FAQ
FAQ
Report problems to the FDA
Report deceptive advertising
Watch & Learn
Browse All
A Patient's Story
DrB's Educational Presentations
Non-Preserved Eye Drop Safety
Regener-Eyes
StimulEyes
Sludge ™
The Placebo Effect
FDA Compliance
On Label, Off Label or No Label?
Placentas from Strangers
History
DEF Open Letter to Key Opinion Leaders (Nov 7, 2024)
FDA Warning Letter to Regenerative Processing Plant (Aug 16, 2024)
FDA Warning Letter to Neobiosis (June 5, 2024)
FDA Inspection Form 483 - RPP Tampa (June 23, 2023)
FDA Inspection Form 483 - RPP Palm Harbor (June 30, 2023)
DEF Open Letter to the FDA (May 12, 2023)
DEF Open Letter to the Eye Care Press (May 5, 2023)
DEF Open Letter to ABB Optical and Dry Eye Rescue (May 1, 2023)
FDA Public Safety Notification on Amniotic Fluid Eyedrops (Apr 10, 2023)
DEF Open Letter re StimulEyes (Mar 9, 2023)
DEF Open Letter to Regener-Eyes (Mar 5, 2023)
FDA Untitled Letter re StimulEyes (Nov 17, 2022)
FDA Untitled Letter to Regener-Eyes (Oct 5, 2022)
DEF Open Letter to Regener-Eyes (Sep 29, 2022)
DEF Regulatory Compliance Summary Information (June 8, 2022)
DEF Open letter for Eye Care Professionals (May 16, 2022)
Home
Folder: FAQ
Back
FAQ
Report problems to the FDA
Report deceptive advertising
Folder: Watch & Learn
Back
Browse All
A Patient's Story
DrB's Educational Presentations
Non-Preserved Eye Drop Safety
Regener-Eyes
StimulEyes
Sludge ™
The Placebo Effect
FDA Compliance
On Label, Off Label or No Label?
Placentas from Strangers
Folder: History
Back
DEF Open Letter to Key Opinion Leaders (Nov 7, 2024)
FDA Warning Letter to Regenerative Processing Plant (Aug 16, 2024)
FDA Warning Letter to Neobiosis (June 5, 2024)
FDA Inspection Form 483 - RPP Tampa (June 23, 2023)
FDA Inspection Form 483 - RPP Palm Harbor (June 30, 2023)
DEF Open Letter to the FDA (May 12, 2023)
DEF Open Letter to the Eye Care Press (May 5, 2023)
DEF Open Letter to ABB Optical and Dry Eye Rescue (May 1, 2023)
FDA Public Safety Notification on Amniotic Fluid Eyedrops (Apr 10, 2023)
DEF Open Letter re StimulEyes (Mar 9, 2023)
DEF Open Letter to Regener-Eyes (Mar 5, 2023)
FDA Untitled Letter re StimulEyes (Nov 17, 2022)
FDA Untitled Letter to Regener-Eyes (Oct 5, 2022)
DEF Open Letter to Regener-Eyes (Sep 29, 2022)
DEF Regulatory Compliance Summary Information (June 8, 2022)
DEF Open letter for Eye Care Professionals (May 16, 2022)
Vitti Labs Warning Letter
Rebecca Petris 8/14/22 Rebecca Petris 8/14/22

Vitti Labs Warning Letter

FDA warning letter to Vitti Labs and why this is relevant to other biologic eye drop manufacturers.

Read More
You Won’t Eat GMO But You’ll Put This In Your Eyes, Part 2
DrB's Educational Presentations Rebecca Petris 8/4/22 DrB's Educational Presentations Rebecca Petris 8/4/22

You Won’t Eat GMO But You’ll Put This In Your Eyes, Part 2

The GoodFellas of StimulEyes: M2 Biologics, Neobiosis, Truax Patient Services

Read More
You Won’t Eat GMO But You’ll Put This In Your Eyes, Part 1
DrB's Educational Presentations Rebecca Petris 7/31/22 DrB's Educational Presentations Rebecca Petris 7/31/22

You Won’t Eat GMO But You’ll Put This In Your Eyes, Part 1

StimulEyes’ FDA Approval Status: “We’re Just Invisible”

Read More
Sludge™
DrB's Educational Presentations Rebecca Petris 7/31/22 DrB's Educational Presentations Rebecca Petris 7/31/22

Sludge™

The highly advertised contents of biologic eye drops - i.e. growth factors and cytokines - are very sensitive to their environment and require tightly controlled conditions to maintain stability. What happens when you fail to provide that environment?

Read More
The FDA and Autologous Serum Tears
DrB's Educational Presentations Rebecca Petris 7/31/22 DrB's Educational Presentations Rebecca Petris 7/31/22

The FDA and Autologous Serum Tears

Have you been told that Biologic Eye Drops (or “BED”, made from placenta or amniotic fluid) are similar to autologous serum tears (AST)? Watch this video to understand why they are actually vastly different from the standpoint of the FDA.

Read More
Outing Regenereyes, Part 6 - How did they do it?
Rebecca's Videos Rebecca Petris 7/31/22 Rebecca's Videos Rebecca Petris 7/31/22

Outing Regenereyes, Part 6 - How did they do it?

How does a company deceive doctors? Lots of doctors? Five not-so-easy steps to successfully take an unapproved eye drop in a Frankenstein bottle… mainstream.

Read More
Outing Regenereyes Part 5 - Recalculating Risk
Rebecca's Videos Rebecca Petris 7/26/22 Rebecca's Videos Rebecca Petris 7/26/22

Outing Regenereyes Part 5 - Recalculating Risk

Recalculating risk in a changing world: Three types of risk you may not have had to think about before while choosing dry eye treatments.

Read More
Outing Regenereyes, Part 4 - The Science
Rebecca's Videos Rebecca Petris 7/20/22 Rebecca's Videos Rebecca Petris 7/20/22

Outing Regenereyes, Part 4 - The Science

No clinical trials, no science, no dice.

Read More
Outing Regenereyes, Part 3 - The Products
Rebecca's Videos Rebecca Petris 7/19/22 Rebecca's Videos Rebecca Petris 7/19/22

Outing Regenereyes, Part 3 - The Products

Regenereyes ophthalmic solutions: What do we know about these eyedrops? How do we know it? What do we not know that we should know?

Read More
Outing Regenereyes, Part 2 - The Company
Rebecca's Videos Rebecca Petris 7/18/22 Rebecca's Videos Rebecca Petris 7/18/22

Outing Regenereyes, Part 2 - The Company

About the journey from seeing a low grade red flag to having much more serious concerns.

Read More
FDA Drug Approval for Biologic Eye Drops, Part 2 - Somewhat Less than the Whole Truth
DrB's Educational Presentations Rebecca Petris 7/14/22 DrB's Educational Presentations Rebecca Petris 7/14/22

FDA Drug Approval for Biologic Eye Drops, Part 2 - Somewhat Less than the Whole Truth

How biologic eye drop manufacturers confuse everyone using the Code of Federal Regulations - from HCT/P to PHS Section 361

Read More
Outing Regenereyes, Part 1 - Introduction
Rebecca's Videos Rebecca Petris 7/14/22 Rebecca's Videos Rebecca Petris 7/14/22

Outing Regenereyes, Part 1 - Introduction

The medical marketplace is changing. Get a preview of the Regener-Eyes story, and learn why this is relevant to all dry eye patients - not just those using or considering Regener-Eyes.

Read More
FDA Drug Approval for Biologic Eye Drops, Part 1 - No Shortcuts Allowed
DrB's Educational Presentations Rebecca Petris 7/14/22 DrB's Educational Presentations Rebecca Petris 7/14/22

FDA Drug Approval for Biologic Eye Drops, Part 1 - No Shortcuts Allowed

How new drugs are approved, including biologics, and where currently marketed biologic eye drops stand.

Read More
Outing Regener-Eyes - Trailer
Rebecca's Videos Rebecca Petris 7/14/22 Rebecca's Videos Rebecca Petris 7/14/22

Outing Regener-Eyes - Trailer

It’s amazing what you can get away with if you just have the guts to tell big enough lies.

Read More
Diagnosing Scam Pharma, Part 2 - The Astonishing New Regener-Eyes Advertisement
DrB's Educational Presentations Rebecca Petris 7/14/22 DrB's Educational Presentations Rebecca Petris 7/14/22

Diagnosing Scam Pharma, Part 2 - The Astonishing New Regener-Eyes Advertisement

Read More
Diagnosing Scam Pharma, Part 1 - The Facebook Photos Biopsy
DrB's Educational Presentations Rebecca Petris 6/27/22 DrB's Educational Presentations Rebecca Petris 6/27/22

Diagnosing Scam Pharma, Part 1 - The Facebook Photos Biopsy

The Facebook Photos Biopsy. Seven telltale ad features.

Read More
Placentas from Strangers, Part 2 -  Biological Eye Drops, Doctors & Scam Pharma
DrB's Educational Presentations Rebecca Petris 6/13/22 DrB's Educational Presentations Rebecca Petris 6/13/22

Placentas from Strangers, Part 2 - Biological Eye Drops, Doctors & Scam Pharma

Real pharma, scam pharma, what the FDA means by “illegal”, and why it can be hard even for good doctors to identify scam pharma.

Read More
On Label, Off Label, No Label, Part 2
DrB's Educational Presentations Rebecca Petris 6/9/22 DrB's Educational Presentations Rebecca Petris 6/9/22

On Label, Off Label, No Label, Part 2

What are the safety implications of moving past drugs whose adverse effects have been documented through clinical trials?

Read More
On Label, Off Label, No Label, Part 1 - How Radical Is Your Doctor?
DrB's Educational Presentations Rebecca Petris 6/5/22 DrB's Educational Presentations Rebecca Petris 6/5/22

On Label, Off Label, No Label, Part 1 - How Radical Is Your Doctor?

The difference between a not-approved drug and an unapproved use of an approved drug.

Read More
Placentas from Strangers, Part 1 - Dry Eye Patients & Scam Pharma
DrB's Educational Presentations Rebecca Petris 6/2/22 DrB's Educational Presentations Rebecca Petris 6/2/22

Placentas from Strangers, Part 1 - Dry Eye Patients & Scam Pharma

What do biologic eye drops have in common with a mocha frappuccino? What’s the difference between real pharma and scam pharma?

Read More
Newer Posts
Older Posts

About

Contact

Join Dry Eye Foundation mailing list(s)

Copyright © 2025. All rights reserved.